Sort by

Send to

Choose Destination

Search results

Items: 10


Simple functional imaging of the right ventricle in pulmonary hypertension: Can right ventricular ejection fraction be improved?

Vanderpool RR, Rischard F, Naeije R, Hunter K, Simon MA.

Int J Cardiol. 2016 Nov 15;223:93-94. doi: 10.1016/j.ijcard.2016.08.138. No abstract available.


Transition from parenteral to oral treprostinil in pulmonary arterial hypertension.

Chakinala MM, Feldman JP, Rischard F, Mathier M, Broderick M, Leedom N, Laliberte K, White RJ.

J Heart Lung Transplant. 2016 Jun 24. pii: S1053-2498(16)30197-8. doi: 10.1016/j.healun.2016.06.019. [Epub ahead of print]


Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.

Tang H, Yamamura A, Yamamura H, Song S, Fraidenburg DR, Chen J, Gu Y, Pohl NM, Zhou T, Jiménez-Pérez L, Ayon RJ, Desai AA, Goltzman D, Rischard F, Khalpey Z, Black SM, Garcia JG, Makino A, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2016 May 1;310(9):L846-59. doi: 10.1152/ajplung.00050.2016. Epub 2016 Mar 11.


Quantitative Right Ventricular Function in Pulmonary Arterial Hypertension: A Quest for a More Reliable Metric.

Abidov A, Rischard F.

Echocardiography. 2016 Feb;33(2):174-6. doi: 10.1111/echo.13151. Epub 2015 Dec 29. No abstract available.


Selexipag for the Treatment of Pulmonary Arterial Hypertension.

Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators.

N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184.


Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators.

N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687.


Selective pulmonary vasodilation improves ventriculovascular coupling and gas exchange in a patient with unrepaired single-ventricle physiology.

Rischard F, Vanderpool R, Jenkins I, Dalabih M, Colombo J, Lax D, Seckeler M.

Pulm Circ. 2015 Jun;5(2):407-11. doi: 10.1086/681269.


What's new: the management of acute right ventricular decompensation of chronic pulmonary hypertension.

Dalabih M, Rischard F, Mosier JM.

Intensive Care Med. 2014 Dec;40(12):1930-3. doi: 10.1007/s00134-014-3459-5. Epub 2014 Sep 3. No abstract available.


Riociguat for the treatment of pulmonary arterial hypertension.

Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group.

N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655.


Ischemia and ischemic preconditioning in the buffer-perfused pigeon heart.

Rischard F, McKean T.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Jan;119(1):59-65.

Items per page

Supplemental Content

Loading ...
Support Center